JFNNX Mutual Fund

JFNNX Mutual Fund

NAV$88.16
See how much of JFNNX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
0.68%
Dividend Yield (Current)
4.14%
Holdings
109
Inception Date
Jan 26, 2018
Fund Family
Janus Henderson Investors
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+8.17%
1 Year+40.28%
3 Year+13.07%
5 Year+8.54%
10 Year+11.34%

Asset Allocation

Stocks: 99.35%
Other: 0.65%
See how much of JFNNX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.8.84%
JNJJohnson & Johnson - Common7.29%
AZN:LNAstraZeneca PLC4.59%
ABBVAbbvie Inc.4.05%
UNHUnitedhealth Group Incorporated3.13%
Top 10 Concentration: 40.52%Report Date: Mar 31, 2026
Download all 109 holdings for JFNNX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
4.14%
Frequency
Annually
Latest Distribution
$6.91
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

JFNNX Mutual Fund Overview

JFNNX Mutual Fund (Janus Henderson Global Life Sciences Fund Class N) is managed by Janus Henderson Investors. JFNNX expense ratio is 0.68%, holding 109 positions across sectors including Health Care, Financials. Inception date: 2018-01-26.

JFNNX performance shows a YTD return of 8.17%. The 1-year return is 40.28% and the 5-year return is 8.54%. JFNNX dividend yield stands at 4.14%, paid annually.

JFNNX top holdings include Eli Lilly & Co. (8.8%), Johnson & Johnson - Common (7.3%), AstraZeneca PLC (4.6%), Abbvie Inc. (4.0%), Unitedhealth Group Incorporated (3.1%). Go to all JFNNX holdings, JFNNX sectors, or JFNNX dividends.

JFNNX can be compared against other funds. Use JFNNX overlap to find shared positions, or JFNNX vs another fund for a side-by-side view. JFNNX alternatives are available via the screener, along with tax-loss harvesting opportunities.